Peroxisome proliferator-activated receptor α activates human multidrug resistance transporter 3/ATP-binding cassette protein subfamily B4 transcription and increases rat biliary phosphatidylcholine secretion-Reference-Cited by-同舟云学术

Peroxisome proliferator-activated receptor α activates human multidrug resistance transporter 3/ATP-binding cassette protein subfamily B4 transcription and increases rat biliary phosphatidylcholine secretion

Published:2014-01-27 Issue:3 Volume:59 Page:1030-1042
ISSN:0270-9139
Container-title:Hepatology
language:en
Short-container-title:Hepatology

Author:

Ghonem Nisanne S.¹,Ananthanarayanan Meenakshisundaram¹,Soroka Carol J.¹,Boyer James L.¹

Affiliation:

1. Department of Internal Medicine, Liver Center; Yale University School of Medicine; New Haven CT

Publisher

Wiley

Subject

Hepatology

Reference40 articles.

1. Genetic analysis of the multidrug transporter;Gottesman;Annu Rev Genet,1995

2. Regulation of biliary lipid secretion by mdr2 P-glycoprotein in the mouse;Elferink;J Clin Invest,1995

3. Bile salt transporters: molecular characterization, function, and regulation;Trauner;Physiol Rev,2003

4. Homozygous disruption of the murine mdr2 P-glycoprotein gene leads to a complete absence of phospholipid from bile and to liver disease;Smit;Cell,1993

5. Ursodeoxycholic acid aggravates bile infarcts in bile duct-ligated and Mdr2 knockout mice via disruption of cholangioles;Fickert;Gastroenterology,2002

Cited by 71 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Effectiveness of 1-year pemafibrate treatment on steatotic liver disease: the influence of alcohol consumption;European Journal of Gastroenterology & Hepatology;2024-03-21

2. Primary Biliary Cholangitis;Clinics in Liver Disease;2024-02

3. Beta-lapachone ameliorates the progression of primary sclerosing cholangitis pathogenesis in rodent models;Life Sciences;2024-01

4. The role of peroxisome proliferator‐activated receptors in the regulation of bile acid metabolism;Basic & Clinical Pharmacology & Toxicology;2023-12-15

5. Treatment of primary sclerosing cholangitis combined with inflammatory bowel disease;Intestinal Research;2023-10-31